4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Makker Gotham
4: Statement of changes in beneficial ownership of securities-Director SOUTHWELL DAVID P
4: Statement of changes in beneficial ownership of securities-Officer Militello John
4: Statement of changes in beneficial ownership of securities-Officer Shah Gaurav
4: Statement of changes in beneficial ownership of securities-Officer Wilson Martin
4: Statement of changes in beneficial ownership of securities-Officer Patel Kinnari
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
10-Q: Quarterly report
8-K: Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress
ARS: Annual Report to Security Holders
DEF 14A: Definitive information statements
DEFA14A: Others
4: Statement of changes in beneficial ownership of securities-Officer Militello John
144: Notice of proposed sale of securities pursuant to Rule 144
PRE 14A: Preliminary proxy statements relating to merger or acquisition
4: Statement of changes in beneficial ownership of securities-Director SOUTHWELL DAVID P
Rocket Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data